April 2026
The global tumor ablation market size is exhibited at USD 2.18 billion in 2025 and is predicted to be worth around USD 7.47 billion by 2035, with a CAGR of 13.11%.
September 2026
The circulating tumor DNA (ctDNA) market size was USD 9.14 billion in 2026, with leading circulating tumor DNA (ctDNA) market players including Guardant Health, Roche Diagnostics, Illumina.
September 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 3.05 billion in 2026, at a solid CAGR of 6.00%.
September 2026
The global cryoballoon ablation system market size was evaluated at USD 1.51 billion in 2026 and is predicted to hit around USD 2.49 billion by 2035, growing at a CAGR of 5.70%.
September 2026
The global microwave ablation devices market size is estimated to hit around USD 1,466.66 million by 2034 increasing from USD 570.00 million in 2026, with a CAGR of 12.54%.
September 2026
The global ventricular tachycardia (VT) ablation market is poised for growth, driven by the increasing prevalence of cardiovascular diseases linked to aging populations and lifestyle changes.
September 2026
The ultrasonic tissue ablation system market reached USD 674.45 million in 2026, with prominent companies such as Insightec, HistoSonics, Profound Medical, EDAP TMS, SonaCare Medical leading the ultrasonic tissue ablation system market.
September 2026
The global cardiac ablation market size was evaluated at USD 6.59 billion in 2026 and is projected to worth around USD 20.82 billion by 2035, with a CAGR of 13.65%.
July 2026
The pan-tumor oncology treatment market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global endometrial ablation market size was exhibited at USD 1.42 billion in 2026 and is projected to surpass around USD 2.26 billion by 2035, with a notable CAGR of 5.29%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global circulating tumor cells market size was evaluated at USD 14.68 billion in 2025 and is predicted to hit around USD 54.76 billion by 2035, growing at a CAGR of 14.07%.
January 2026
The global electrophysiology ablation market size was evaluated at USD 7.17billion in 2025 and is predicted to hit around USD 21.86 billion by 2035, growing at a CAGR of 11.80%.
November 2025
The global ablation devices market size is evaluated at USD 11.88 billion in 2026 and is predicted to hit around USD 26.64 billion by 2035, with a CAGR of 9.41%.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.